My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 186

    1.

    Lipoatrophy, lipodystrophy, and insulin resistance.

    Ganda OP.

    Ann Intern Med. 2000 Aug 15;133(4):304-6. No abstract available. PMID: 10929174 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes.

    Arioglu E, Duncan-Morin J, Sebring N, Rother KI, Gottlieb N, Lieberman J, Herion D, Kleiner DE, Reynolds J, Premkumar A, Sumner AE, Hoofnagle J, Reitman ML, Taylor SI.

    Ann Intern Med. 2000 Aug 15;133(4):263-74.PMID: 10929166 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    New diabetes drug targets insulin resistance.

    [No authors listed]

    Am J Health Syst Pharm. 1997 Mar 15;54(6):623, 625. No abstract available. PMID: 9075488 [PubMed - indexed for MEDLINE]Related articles

    4.

    New directions in treating insulin resistance.

    Reusch JE.

    Hosp Pract (Minneap). 1995 Sep 15;30(9):9-10. No abstract available. PMID: 7559840 [PubMed - indexed for MEDLINE]Related articles

    5.

    Learning to use troglitazone.

    Riddle MC.

    Diabetes Care. 1998 Sep;21(9):1389-90. Review. No abstract available. PMID: 9727881 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    [Thiazolidinediones]

    Scheen AJ, Paquot N, Letiexhe MR, Lefèbvre PJ.

    Journ Annu Diabetol Hotel Dieu. 1999:213-29. Review. French. No abstract available. PMID: 10732419 [PubMed - indexed for MEDLINE]Related articles

    7.

    [Troglitazone, an insulin action enhancer--a drug of precision to treat adult-onset diabetes]

    Westerbacka J, Yki-Järvinen H.

    Duodecim. 1997;113(19):1847-8. Finnish. No abstract available. PMID: 10892078 [PubMed - indexed for MEDLINE]Related articles

    8.

    Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones.

    Chao L, Marcus-Samuels B, Mason MM, Moitra J, Vinson C, Arioglu E, Gavrilova O, Reitman ML.

    J Clin Invest. 2000 Nov;106(10):1221-8.PMID: 11086023 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Troglitazone and small low-density lipoprotein in type 2 diabetes.

    Hirano T, Yoshino G, Kazumi T.

    Ann Intern Med. 1998 Jul 15;129(2):162-3. No abstract available. PMID: 9669982 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Thiazolidinediones for type 2 diabetes. New agents reduce insulin resistance but need long term clinical trials.

    Krentz AJ, Bailey CJ, Melander A.

    BMJ. 2000 Jul 29;321(7256):252-3. No abstract available. PMID: 10915108 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Insulin resistance and the prevention of diabetes mellitus.

    Keen H.

    N Engl J Med. 1994 Nov 3;331(18):1226-7. No abstract available. PMID: 7935664 [PubMed - indexed for MEDLINE]Related articles

    12.

    [Insulin-sensitizing agents and hypertension]

    Naruse M, Yoshimoto T, Tanabe A, Takagi S, Tago K, Takano K.

    Nippon Rinsho. 2000 Feb;58 Suppl 2:431-4. Review. Japanese. No abstract available. PMID: 11028373 [PubMed - indexed for MEDLINE]Related articles

    13.

    Thiazolidinediones, dyslipidaemia and insulin resistance syndrome.

    Sunayama S, Watanabe Y, Daida H, Yamaguchi H.

    Curr Opin Lipidol. 2000 Aug;11(4):397-402. Review.PMID: 10945722 [PubMed - indexed for MEDLINE]Related articles

    14.

    Effect of troglitazone on lipoprotein(a) levels in obese subjects.

    Tack CJ, Smits P, DeMacker PN, Stalenhoef AF.

    Diabetes Care. 1999 Oct;22(10):1752-3. No abstract available. PMID: 10526754 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    From fat-free mice, the skinny on diabetes.

    Gura T.

    Science. 1998 Oct 23;282(5389):604. No abstract available. PMID: 9841407 [PubMed - indexed for MEDLINE]Related articles

    16.

    "Glitazones", a prospect for non-insulin-dependent diabetes.

    Petrie J, Small M, Connell J.

    Lancet. 1997 Jan 11;349(9045):70-1. No abstract available. PMID: 8996411 [PubMed - indexed for MEDLINE]Related articles

    17.

    Insulin-sensitising agents in polycystic-ovary syndrome.

    Sattar N, Hopkinson ZE, Greer IA.

    Lancet. 1998 Jan 31;351(9099):305-7. No abstract available. PMID: 9652605 [PubMed - indexed for MEDLINE]Related articles

    18.

    Insulin resistance and its treatment by thiazolidinediones.

    Lebovitz HE, Banerji MA.

    Recent Prog Horm Res. 2001;56:265-94. Review.PMID: 11237217 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Troglitazone not only reduced insulin resistance but also improved myotonia in a patient with myotonic dystrophy.

    Kashiwagi K, Nagafuchi S, Sekiguchi N, Yamagata A, Iwata I, Furuya H, Kato M, Niho Y.

    Eur Neurol. 1999;41(3):171-2. No abstract available. PMID: 10202252 [PubMed - indexed for MEDLINE]Related articles

    20.

    [Combination therapy of insulin sensitizer, thiazolidinedione drugs, and sulfonylurea]

    Ohmura E, Hosaka D, Imai Y, Kawazu S.

    Nippon Rinsho. 2002 Sep;60 Suppl 9:470-5. Review. Japanese. No abstract available. PMID: 12387036 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity